Conyers provided Cayman Islands legal advice to New Horizon Health Limited (“New Horizon”) in connection with its HK$2.02 billion global offering of 76,598,000 shares on the Main Board of The Stock Exchange of Hong Kong (Stock Code: 6606).

New Horizon is a cancer screening bio-tech firm whose retail offering was 4133 times over-subscribed, the second highest on record.

Partner Christopher Bickley of Conyers’ Hong Kong office advised on the matter, working alongside Davis Polk & Wardell and Fangda Partners.


Stay current with our latest legal insights and subscribe today